Surprisingly, it was widely demonstrated that GnRH antagonists act as agonists in cancer cells, including PCa cells, exerting a significant antiproliferative/proapoptotic activity both in vitro and in vivo [24,25,26,29,200,201,202]. The gene discussed is GNRH1; the disease is cancer.